Erxi Wu Selected Research

6- methoxy- 3- (3',4',5'- trimethoxybenzoyl)- 1H- indole

1/2013

An antimitotic and antivascular agent BPR0L075 overcomes multidrug resistance and induces mitotic catastrophe in paclitaxel-resistant ovarian cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erxi Wu Research Topics

Disease

45	Neoplasms (Cancer) 06/2022 - 06/2006
32	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022 - 01/2011
8	Hyperglycemia 10/2015 - 11/2008
6	Inflammation (Inflammations) 01/2022 - 10/2009
6	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2011
6	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 09/2006
5	Infections 06/2022 - 11/2013
4	Carcinogenesis 01/2014 - 01/2010
3	Lung Neoplasms (Lung Cancer) 06/2022 - 09/2014
3	Dementia (Dementias) 07/2021 - 09/2017
3	Pain (Aches) 01/2020 - 03/2013
3	Medulloblastoma 02/2015 - 01/2011
2	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2020 - 01/2020
2	Multiple System Atrophy 06/2020 - 05/2015
2	Synucleinopathies 01/2020 - 05/2015
2	Neuroblastoma 01/2019 - 05/2009
2	Ischemia 01/2018 - 01/2018
2	Sepsis (Septicemia) 11/2016 - 08/2014
2	Prostatic Neoplasms (Prostate Cancer) 06/2016 - 01/2013
2	Ovarian Neoplasms (Ovarian Cancer) 12/2015 - 01/2013
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 09/2015 - 01/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2015 - 01/2015
2	Hypoxia (Hypoxemia) 05/2014 - 06/2013
2	Breast Neoplasms (Breast Cancer) 10/2009 - 04/2009
1	Fibrosarcoma 06/2022
1	COVID-19 06/2022
1	Chronic Pancreatitis 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Circulating Neoplastic Cells 01/2021
1	Neurobehavioral Manifestations 12/2020
1	Edema (Dropsy) 11/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2020
1	Wounds and Injuries (Trauma) 11/2020
1	Gliosis 01/2020
1	Disease Progression 01/2020
1	Seizures (Absence Seizure) 01/2020
1	Brain Edema (Cerebral Edema) 01/2020
1	Nerve Degeneration 01/2020

Drug/Important Bio-Agent (IBA)

12	Pharmaceutical PreparationsIBA 01/2022 - 09/2006
11	Proteins (Proteins, Gene)FDA Link 11/2021 - 05/2009
9	CytokinesIBA 01/2021 - 01/2013
6	Gemcitabine FDA Link 04/2022 - 08/2011
6	Biological ProductsIBA 01/2022 - 01/2013
6	ResveratrolIBA 01/2020 - 01/2013
6	Small Interfering RNA (siRNA)IBA 12/2015 - 09/2012
6	Glucose (Dextrose)FDA LinkGeneric 10/2015 - 01/2011
5	salinomycinIBA 01/2022 - 01/2013
4	SynucleinsIBA 01/2021 - 05/2015
4	Nerve Growth Factor (NGF)IBA 01/2020 - 02/2011
3	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2012
3	Superoxide DismutaseIBA 01/2018 - 05/2015
3	EnzymesIBA 08/2015 - 10/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2014 - 04/2009
3	Messenger RNA (mRNA)IBA 01/2014 - 04/2009
3	LigandsIBA 06/2013 - 01/2012
3	Matrix Metalloproteinases (MMPs)IBA 03/2013 - 10/2009
2	theanineIBA 06/2022 - 09/2014
2	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 01/2022 - 04/2016
2	Caspase 3 (Caspase-3)IBA 11/2020 - 01/2013
2	Substance PIBA 01/2020 - 03/2013
2	Fluorouracil (Carac)FDA LinkGeneric 11/2018 - 01/2014
2	Free RadicalsIBA 01/2018 - 01/2014
2	AMP-Activated Protein KinasesIBA 01/2017 - 08/2015
2	p38 Mitogen-Activated Protein KinasesIBA 10/2015 - 01/2014
2	DNA-Binding Proteins (DNA Binding Protein)IBA 09/2015 - 01/2015
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 02/2015 - 01/2011
2	mangostinIBA 05/2014 - 01/2014
2	matrigelIBA 01/2014 - 03/2013
2	Blood Glucose (Blood Sugar)IBA 01/2014 - 01/2011
2	cyclopamineIBA 06/2013 - 09/2012
2	Antineoplastic Agents (Antineoplastics)IBA 01/2013 - 10/2009
2	Cadherins (E-Cadherin)IBA 01/2013 - 01/2013
2	Therapeutic UsesIBA 01/2013 - 04/2009
2	Epidermal Growth Factor (EGF)IBA 01/2011 - 04/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2010 - 03/2007
2	TOR Serine-Threonine KinasesIBA 01/2010 - 03/2007
2	NF-kappa B (NF-kB)IBA 10/2009 - 04/2009
1	Nucleotide AptamersIBA 06/2022
1	ethyl 6-bromocoumarin-3-carboxylyl theanineIBA 06/2022
1	TeaIBA 06/2022
1	LipopolysaccharidesIBA 01/2022
1	lipopolysaccharide-binding proteinIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	PlacebosIBA 07/2021
1	Glutamic Acid (Glutamate)FDA Link 12/2020
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 11/2020
1	Protein SIBA 11/2020
1	piperineIBA 01/2020
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 01/2020
1	Calcitonin Gene-Related PeptideIBA 01/2020
1	Cholinergic Agents (Cholinergics)IBA 01/2020
1	Pentylenetetrazole (Metrazol)IBA 01/2020
1	Caveolin 1IBA 01/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020

Therapy/Procedure

21	Therapeutics 06/2022 - 11/2007
9	Drug Therapy (Chemotherapy) 04/2022 - 06/2006
2	Punctures 01/2021 - 11/2016
2	Ligation 01/2021 - 11/2016
1	Aftercare (After-Treatment) 07/2021
1	Immunotherapy 11/2020